Description
CJC-1295 (No DAC), also known as Modified GRF (1-29), is a short-acting synthetic analog of growth hormone-releasing hormone lacking the drug affinity complex. Researchers use it as a GHRH receptor agonist with brief activity.
In cultured cells and laboratory animals, work has focused on growth hormone release, GHRH receptor signaling, and pulsatile secretion patterns. Its quick clearance suits short-interval, time-resolved study designs.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.






Reviews
There are no reviews yet.